HK1109350A1 - Solid forms of a chemokine receptor antagonist and methods of use thereof - Google Patents
Solid forms of a chemokine receptor antagonist and methods of use thereofInfo
- Publication number
- HK1109350A1 HK1109350A1 HK08103587.5A HK08103587A HK1109350A1 HK 1109350 A1 HK1109350 A1 HK 1109350A1 HK 08103587 A HK08103587 A HK 08103587A HK 1109350 A1 HK1109350 A1 HK 1109350A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- citrate salt
- methods
- crystalline
- discussed
- receptor antagonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63721304P | 2004-12-17 | 2004-12-17 | |
PCT/US2005/045915 WO2006066200A2 (fr) | 2004-12-17 | 2005-12-19 | Formes solides d'un antagoniste du recepteur de la chimiokine et leurs methodes d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1109350A1 true HK1109350A1 (en) | 2008-06-06 |
Family
ID=36588631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08103587.5A HK1109350A1 (en) | 2004-12-17 | 2008-04-01 | Solid forms of a chemokine receptor antagonist and methods of use thereof |
Country Status (10)
Country | Link |
---|---|
US (2) | US7960549B2 (fr) |
EP (1) | EP1841429B1 (fr) |
JP (3) | JP5308030B2 (fr) |
CN (1) | CN101119725B (fr) |
AT (1) | ATE553761T1 (fr) |
AU (1) | AU2005316340B2 (fr) |
CA (1) | CA2590157C (fr) |
ES (1) | ES2386029T3 (fr) |
HK (1) | HK1109350A1 (fr) |
WO (1) | WO2006066200A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2023505116A (ja) * | 2019-11-29 | 2023-02-08 | ▲広▼▲東▼▲東▼▲陽▼光▲薬▼▲業▼有限公司 | 三環式含窒素化合物の結晶形及びその用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6509346B2 (en) | 1998-01-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
BR9910144A (pt) | 1998-01-21 | 2002-04-02 | Millennium Pharm Inc | Antagonistas de receptores de quimiocinas e seu uso |
US6433165B1 (en) * | 1998-01-21 | 2002-08-13 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
US6613905B1 (en) * | 1998-01-21 | 2003-09-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
WO2003045942A2 (fr) * | 1998-09-04 | 2003-06-05 | Millennium Pharmaceuticals, Inc. | Antagonistes des recepteurs de la chimiokine et methodes d'utilisation de ces antagonistes |
JP2002524461A (ja) | 1998-09-04 | 2002-08-06 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | ケモカイン受容体アンタゴニストおよびその使用方法 |
US7271176B2 (en) * | 1998-09-04 | 2007-09-18 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use thereof |
US6503926B2 (en) | 1998-09-04 | 2003-01-07 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
US20020169155A1 (en) * | 1998-09-04 | 2002-11-14 | Millennium Pharmaceuticals, Inc. | Chemokine receptor anagonists and methods of use therefor |
US6288083B1 (en) * | 1998-09-04 | 2001-09-11 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
WO2001009137A1 (fr) | 1999-07-28 | 2001-02-08 | Millennium Pharmaceuticals, Inc. | Antagonistes de recepteur de chemokine et procedes d'utilisation |
US7541365B2 (en) | 2001-11-21 | 2009-06-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
TWI291467B (en) * | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
-
2005
- 2005-12-19 CA CA2590157A patent/CA2590157C/fr not_active Expired - Fee Related
- 2005-12-19 US US11/311,574 patent/US7960549B2/en not_active Expired - Fee Related
- 2005-12-19 WO PCT/US2005/045915 patent/WO2006066200A2/fr active Application Filing
- 2005-12-19 ES ES05854594T patent/ES2386029T3/es active Active
- 2005-12-19 EP EP05854594A patent/EP1841429B1/fr active Active
- 2005-12-19 JP JP2007547000A patent/JP5308030B2/ja not_active Expired - Fee Related
- 2005-12-19 AU AU2005316340A patent/AU2005316340B2/en not_active Ceased
- 2005-12-19 CN CN2005800481176A patent/CN101119725B/zh not_active Expired - Fee Related
- 2005-12-19 AT AT05854594T patent/ATE553761T1/de active
-
2008
- 2008-04-01 HK HK08103587.5A patent/HK1109350A1/xx not_active IP Right Cessation
-
2011
- 2011-05-26 US US13/116,130 patent/US8481737B2/en not_active Expired - Fee Related
-
2012
- 2012-08-02 JP JP2012172003A patent/JP2012211197A/ja not_active Withdrawn
-
2014
- 2014-12-22 JP JP2014258340A patent/JP2015057445A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20120065223A1 (en) | 2012-03-15 |
WO2006066200A3 (fr) | 2007-01-25 |
JP2015057445A (ja) | 2015-03-26 |
EP1841429B1 (fr) | 2012-04-18 |
JP5308030B2 (ja) | 2013-10-09 |
AU2005316340B2 (en) | 2012-01-19 |
CA2590157A1 (fr) | 2006-06-22 |
US8481737B2 (en) | 2013-07-09 |
JP2012211197A (ja) | 2012-11-01 |
CN101119725A (zh) | 2008-02-06 |
JP2008524253A (ja) | 2008-07-10 |
WO2006066200A2 (fr) | 2006-06-22 |
ES2386029T3 (es) | 2012-08-07 |
ATE553761T1 (de) | 2012-05-15 |
CN101119725B (zh) | 2013-04-17 |
EP1841429A2 (fr) | 2007-10-10 |
US20070010545A1 (en) | 2007-01-11 |
CA2590157C (fr) | 2013-11-05 |
US7960549B2 (en) | 2011-06-14 |
AU2005316340A1 (en) | 2006-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL168056A0 (en) | Selected cgrp antagonists, method for production and use thereof as medicament | |
GEP20063905B (en) | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament | |
HRP20130602T1 (en) | 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases | |
WO2005016261A3 (fr) | Sels de pamoate d'aripiprazole et d'haloperidol | |
WO2005089753A3 (fr) | Benzisoxazoles | |
PL1732917T3 (pl) | Wybrani antagoniści CGRP, sposoby ich produkcji i ich zastosowanie jako leki | |
WO2003084539A3 (fr) | Nouvelles compositions pharmaceutiques a base d'anticholinergiques et d'inhibiteurs de la kinase p38 | |
WO2005107726A3 (fr) | Procede pour le traitement de mal de dos | |
HUP0400333A3 (en) | Crystalline anticholinergic, method for its production, and use thereof in the production of pharmaceutical composition | |
MY153198A (en) | Inhibitors of protein aggregation | |
IL191311A (en) | Transdermal therapeutic system and its use in the preparation of drugs for the prevention, treatment or delay of the progression of Alzheimer's disease, Parkinson's disease-related dementia and symptoms of traumatic brain injury | |
WO2005089486A3 (fr) | Traitement anti-alcoolique | |
IL226313A0 (en) | A method for producing gamma-carboxylated human prothrombin, isolated prothrombin produced by such a method, a pharmaceutical preparation including it and its use as drugs and for the production of drugs for the treatment of blood coagulation | |
WO2006047392A3 (fr) | Synergie entre nicotine et opioides a des fins d'analgesie | |
MY154878A (en) | Process for purifying staurosporine | |
HK1093729A1 (en) | Substituted quinolones | |
WO2005089449A3 (fr) | Methodes de traitement de l'alcoolisme | |
WO2004103283A3 (fr) | Compositions comprenant un inhibiteur selectif de cyclooxygenase-2 et un stimulant de systeme nerveux central pour le traitement d'une lesion du systeme nerveux central | |
WO2004081043A3 (fr) | Variants de baff et leurs methodes d'utilisation | |
WO2005039578A3 (fr) | Utilisation de derive desoxynojirimycine ou de l'un de ses sels pharmaceutiquement admis | |
WO2004082584A3 (fr) | Utilisation d'antagonistes du recepteur 5-ht2c pour traiter la schizophrenie | |
HK1109350A1 (en) | Solid forms of a chemokine receptor antagonist and methods of use thereof | |
WO2006034106A3 (fr) | Variantes baff et procedes associes | |
WO2007013962A3 (fr) | Compositions de modafinil a action rapide et de courte duree et procedes d'utilisation de celles-ci | |
WO2005094798A3 (fr) | Compositions pharmaceutiques a base d'anticholinergiques et d'antagonistes du recepteur ccr2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20151219 |